These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 17764210)

  • 21. Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence.
    Hill SA; Booth RA; Santaguida PL; Don-Wauchope A; Brown JA; Oremus M; Ali U; Bustamam A; Sohel N; McKelvie R; Balion C; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):421-38. PubMed ID: 24957908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
    Piechota WN; Piechota WT; Bejm J; Wierzbowski R; Michałkiewicz D
    Adv Med Sci; 2006; 51():164-7. PubMed ID: 17357300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
    Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
    Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
    El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.
    Bruins S; Fokkema MR; Römer JW; Dejongste MJ; van der Dijs FP; van den Ouweland JM; Muskiet FA
    Clin Chem; 2004 Nov; 50(11):2052-8. PubMed ID: 15345664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure.
    Emdin M; Passino C; Prontera C; Fontana M; Poletti R; Gabutti A; Mammini C; Giannoni A; Zyw L; Zucchelli G; Clerico A
    Clin Chem; 2007 Jul; 53(7):1289-97. PubMed ID: 17495021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods.
    Oremus M; McKelvie R; Don-Wauchope A; Santaguida PL; Ali U; Balion C; Hill S; Booth R; Brown JA; Bustamam A; Sohel N; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):413-9. PubMed ID: 24953975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natriuretic peptides in heart failure and acute coronary syndrome.
    Gaggin HK; Januzzi JL
    Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-type natriuretic peptides for prediction and diagnosis of weaning failure from cardiac origin.
    Zapata L; Vera P; Roglan A; Gich I; Ordonez-Llanos J; Betbesé AJ
    Intensive Care Med; 2011 Mar; 37(3):477-85. PubMed ID: 21152896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
    Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the value of B-type natriuretic peptide testing for diagnosis, prognosis or monitoring of critically ill adult patients in intensive care?
    Christenson RH
    Clin Chem Lab Med; 2008; 46(11):1524-32. PubMed ID: 18847367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review.
    Santaguida PL; Don-Wauchope AC; Oremus M; McKelvie R; Ali U; Hill SA; Balion C; Booth RA; Brown JA; Bustamam A; Sohel N; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):453-70. PubMed ID: 25062653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
    Ibrahim N; Januzzi JL
    Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients.
    O'Hanlon R; O'Shea P; Ledwidge M; O'Loughlin C; Lange S; Conlon C; Phelan D; Cunningham S; McDonald K
    J Card Fail; 2007 Feb; 13(1):50-5. PubMed ID: 17339003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.
    Alehagen U; Goetze JP; Dahlström U
    Clin Chim Acta; 2007 Jul; 382(1-2):8-14. PubMed ID: 17433809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BNP in the diagnosis and risk stratification of heart failure.
    Moe GW
    Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: is BNP or NT-proBNP a useful assessment tool?
    Balion CM; McKelvie RS; Reichert S; Santaguida P; Booker L; Worster A; Raina P; McQueen MJ; Hill S
    Clin Biochem; 2008 Mar; 41(4-5):266-76. PubMed ID: 17991434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.